drugset / Trial / NCT03924791

Transforaminal Epidural Injection in Acute Sciatica

NCT03924791

RandomizedParallel-groupOpen-labelTreatment

Summary

Patients suffering from sciatica are treated conservatively for the first 8 weeks due to the favourable prognosis. This period is preferably extended up to 14-16 weeks after which patients may opt for surgery. However, patients may experience severe discomfort due to pain in the leg which can lead to decreased physical activity and socio-economic problems. An adequate therapy to alleviate symptoms during this period of 'wait-and-see' is lacking. In this study, patients will be randomized to treatment with transforaminal epidural injections or standard oral pain medication.

Timeline

Start
2019-06-01
Primary completion
2025-12
Completion
2026-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 10 mg Other
Subject Lidocaine Other / unclassified 1 % Other
Subject Lidocaine Other / unclassified 1.5 ml Other
Subject Lidocaine Other / unclassified 2 % Other
Subject Methylprednisolone Other / unclassified 40 mg Other